Long lasting response with trabectedin monotherapy in relapsed metastatic mesenchymal chondrosarcoma

ConclusionThis report aims to present a comprehensive review into available and newer treatment choices for mesenchymal chondrosarcoma, and to highlight trabectedin monotherapy as a possible therapeutic option for mesenchymal chondrosarcoma in the relapsed setting.
Source: Clinical Sarcoma Research - Category: Cancer & Oncology Source Type: research